cis-Aconityl spacer between daunomycin and macromolecular carriers: a model of pH-sensitive linkage releasing drug from a lysosomotropic conjugate.
暂无分享,去创建一个
[1] W. Shen,et al. Conjugation of methotrexate to poly (L‐lysine) as a potential way to overcome drug resistance , 1980, Cancer.
[2] R. Levy,et al. The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities. , 1975, Cancer research.
[3] M. L. Bender. GENERAL ACID-BASE CATALYSIS IN THE INTRAMOLECULAR HYDROLYSIS OF PHTHALAMIC ACID1 , 1957 .
[4] M. Monsigny,et al. Preparation and biological properties of a covalent antitumor drug—arm—carrier (DAC conjugate) , 1980, FEBS letters.
[5] A. Blair,et al. Antibody-linked cytotoxic agents in the treatment of cancer: current status and future prospects. , 1978, Journal of the National Cancer Institute.
[6] M. Masquelier,et al. Amino acid and dipeptide derivatives of daunorubicin. 1. Synthesis, physicochemical properties, and lysosomal digestion. , 1980, Journal of medicinal chemistry.
[7] W. Shen,et al. Poly (L-lysine) and poly (D-lysine) conjugates of methotrexate: different inhibitory effect on drug resistant cells. , 1979, Molecular pharmacology.